115 related articles for article (PubMed ID: 6309883)
1. Cushing's syndrome secondary to ectopic cortisol production by an ovarian carcinoma.
Marieb NJ; Spangler S; Kashgarian M; Heimann A; Schwartz ML; Schwartz PE
J Clin Endocrinol Metab; 1983 Oct; 57(4):737-40. PubMed ID: 6309883
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
3. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H
J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
[TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.
Lacroix A; Bolté E; Tremblay J; Dupré J; Poitras P; Fournier H; Garon J; Garrel D; Bayard F; Taillefer R
N Engl J Med; 1992 Oct; 327(14):974-80. PubMed ID: 1325608
[TBL] [Abstract][Full Text] [Related]
5. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
Reznik Y; Allali-Zerah V; Chayvialle JA; Leroyer R; Leymarie P; Travert G; Lebrethon MC; Budi I; Balliere AM; Mahoudeau J
N Engl J Med; 1992 Oct; 327(14):981-6. PubMed ID: 1325609
[TBL] [Abstract][Full Text] [Related]
6. Cushing's syndrome due to an ACTH-producing primary ovarian carcinoma.
Al Ojaimi EH
Hormones (Athens); 2014; 13(1):140-5. PubMed ID: 24722135
[TBL] [Abstract][Full Text] [Related]
7. Effect of o,p'-DDD on cortisol metabolism in Cushing's syndrome of various etiology.
Koide Y; Inoue S; Murayama H; Kawai K; Yamashita K
Endocrinol Jpn; 1985 Oct; 32(5):615-24. PubMed ID: 3004927
[TBL] [Abstract][Full Text] [Related]
8. Use of ketoconazole in the treatment of Cushing's syndrome.
Loli P; Berselli ME; Tagliaferri M
J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
[TBL] [Abstract][Full Text] [Related]
9. Cushing's syndrome due to adrenal adenoma with persistent diurnal cortisol secretory rhythm.
Olsen NJ; Fang VS; DeGroot LJ
Metabolism; 1978 Jun; 27(6):695-700. PubMed ID: 206799
[TBL] [Abstract][Full Text] [Related]
10. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
11. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
[TBL] [Abstract][Full Text] [Related]
12. Different sensitivity to adrenocorticotropin of dispersed adrenocortical cells from patients with Cushing's disease with macronodular and diffuse adrenal hyperplasia.
Lamberts SW; Bons EG; Bruining HA
J Clin Endocrinol Metab; 1984 Jun; 58(6):1106-10. PubMed ID: 6327752
[TBL] [Abstract][Full Text] [Related]
13. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
Schteingart DE; McKenzie AK
J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
[TBL] [Abstract][Full Text] [Related]
14. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
15. Ectopic ACTH syndrome associated with ovarian steroid-cell tumor.
Sworczak K; Blaut K; Malecha M; Lewczuk A
J Endocrinol Invest; 2002 Apr; 25(4):369-72. PubMed ID: 12030610
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
Johannesen O; Jørgensen H; Frey H; Norman N
Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
[TBL] [Abstract][Full Text] [Related]
17. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland.
Lamberts SW; Zuiderwijk J; Uitterlinden P; Blijd JJ; Bruining HA; de Jong FH
J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930
[TBL] [Abstract][Full Text] [Related]
18. Cushing's syndrome due to unilateral adrenal nodular hyperplasia with incomplete inhibition of the contralateral gland.
Catania A; Reschini E; Orsatti A; Motta P; Airaghi L; Cantalamessa L
Horm Res; 1986; 23(1):9-15. PubMed ID: 3000913
[TBL] [Abstract][Full Text] [Related]
19. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
20. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
